Log in to search using one of your social media accounts:

 

Pravastatin Recalled Over Bupropion Mix-Up (FREE)
By the Editors One lot of pravastatin tablets (40 mg, 30-tablet bottles) manufactured by International Laboratories, LLC has … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 14, 2017 Category: Primary Care Source Type: news

Pravastatin Tablets Recalled, Contain Antidepressant Pravastatin Tablets Recalled, Contain Antidepressant
One lot of the cholesterol-lowering statin was mislabeled and instead contains an antidepressant.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 11, 2017 Category: Consumer Health News Tags: Cardiology News Alert Source Type: news

International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Pravastatin Sodium Tablets USP, 40mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-925-16; Lot # 115698A
International Laboratories, LLC is voluntarily recalling one (1) Lot of Pravastatin Sodium Tablets USP 40 mg packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Pravastatin Sodium Tablets USP 40 mg but contained Bupropion Hydrochloride XL 300 mg tablets. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2017 Category: Food Science Source Type: news

Pravastatin Doesn't Improve Clinical Outcomes in Seniors (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Older adults with hypertension and hyperlipidemia might not benefit from taking pravastatin for primary prevention of cardiovascular events, according to an open-label study in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 22, 2017 Category: Primary Care Source Type: news

Study Casts Doubt on Need for Statins in the'Healthy Old '
MONDAY, May 22, 2017 -- Senior citizens with no history of heart problems appear to gain no health benefit from cholesterol-lowering statin drugs, a new study suggests. People 65 and older treated with pravastatin (Pravachol) as part of a major... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 22, 2017 Category: General Medicine Source Type: news

Pitavastatin an Option for High LDL-C With Antiretrovirals for HIV Pitavastatin an Option for High LDL-C With Antiretrovirals for HIV
It seemed more potent against LDL than pravastatin in a small trial; other statins may interfere with some anti-HIV drugs. Virologic failure or serious adverse events weren't seen with either statin.Heartwire from Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 24, 2017 Category: Cardiology Tags: Cardiology News Source Type: news

Pitavastatin Bests Pravastatin In HIV+ Adults with Dyslipidemia (CME/CE)
(MedPage Today) -- Trial showed superiority in lowering LDL (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 17, 2017 Category: Primary Care Source Type: news

Pravastatin Does Not Improve Survival in Small - Cell Lung Cancer
Median overall survival of 10.6 versus 10.7 months for pravastatin versus placebo added to chemo (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - March 2, 2017 Category: Respiratory Medicine Tags: Internal Medicine, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

Pravastatin Shows Promise in Pregnant Women With Antiphospholipid Syndrome Pravastatin Shows Promise in Pregnant Women With Antiphospholipid Syndrome
Pravastatin may improve pregnancy outcomes in women with antiphospholipid syndrome (APS) refractory to standard antithrombotic therapy, a new study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 1, 2016 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Pravachol (Pravastatin Sodium) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 25, 2016 Category: Drugs & Pharmacology Source Type: news

Progeria triple-therapy findings ‘disappointing’
Pravastatin and zoledronic acid provide no additional clinically relevant benefit to lonafarnib monotherapy for patients with Hutchinson-Gilford progeria syndrome, study findings indicate. (Source: MedWire News)
Source: MedWire News - July 12, 2016 Category: Consumer Health News Tags: Cardiology Source Type: news

Lupus Lipids Improve With Combo Tx (CME/CE)
(MedPage Today) -- Treatment with pravastatin and ezetimibe also benefited endothelial function (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 12, 2016 Category: Primary Care Source Type: news

pravastatin, Pravigard PAC (discontinued)
Title: pravastatin, Pravigard PAC (discontinued)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 10/9/2015 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - October 9, 2015 Category: Drugs & Pharmacology Source Type: news

Pravastatin Shows Promise for Treating Severe PreeclampsiaPravastatin Shows Promise for Treating Severe Preeclampsia
Pravastatin reduces markers of endothelial dysfunction in vitro and stabilizes blood pressure in women with severe preeclampsia, according to a new pilot study. Reuters Health Information (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - August 10, 2015 Category: OBGYN Tags: Ob/Gyn & Women ' s Health News Source Type: news

Pravastatin could save pregnant women from potentially fatal high blood pressure
Experts, including researchers at Aston University in Birmingham, hope the discovery will lead to a new treatment for pre-eclampsia, which is linked to one in 20 stillbirths. (Source: the Mail online | Health)
Source: the Mail online | Health - August 8, 2015 Category: Consumer Health News Source Type: news

Synthetic biology breakthrough leads to cheaper statin production
Researchers have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 27, 2015 Category: Science Source Type: news

Mixed Results for Low-Dose Statin in Second Stroke
(MedPage Today) -- Pravastatin didn't reduce incidence of recurrent stroke, but did offer other benefits. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 16, 2015 Category: Geriatrics Source Type: news

WOSCOPS at 20 Years Shows 'Lifetime' Benefit of StatinsWOSCOPS at 20 Years Shows 'Lifetime' Benefit of Statins
Pravastatin benefits in the first 5 years seemed to produce "lifetime" CHD risk reductions, say investigators. There were also welcome insights about one of the nagging concerns over statin therapy. Heartwire (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 20, 2014 Category: Cardiology Tags: Cardiology News Source Type: news

Statins given early decrease progression of kidney disease
(University of Colorado Denver) Results from a study by University of Colorado School of Medicine researchers show that pravastatin, a medicine widely used for treatment of high cholesterol, also slows down the growth of kidney cysts in children and young adults with autosomal dominant polycystic kidney disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 8, 2014 Category: Biology Source Type: news

New guidelines for taking cholesterol-lowering drugs target cardiovascular risk, not cholesterol level
For years, doctors prescribed the cholesterol-lowering drugs known as statins based largely on cholesterol test results. But new guidelines from the American Heart Association and the American College of Cardiology propose a major change to that strategy, reports the February 2014 Harvard Heart Letter. "The new guidelines shift away from a target-driven approach to a risk-driven approach," says Dr. Reena Pande, a cardiologist at Harvard-affiliated Brigham and Women's Hospital and an instructor in medicine at Harvard Medical School. Instead of striving to reach a specific cholesterol value, doctors should consider...
Source: New Harvard Health Information - January 27, 2014 Category: Consumer Health News Source Type: news

Is your statin affecting your memory? Study finds some common brands can affect brain function
Researchers at the University of Bristol found that Pravastatin (or Pravachol) has adverse effects on memory but that Lipitor has no effect. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2013 Category: Consumer Health News Source Type: news

Kowa, Eli Lilly report results of pre-specified safety analysis of INTREPID trial
Kowa Pharmaceuticals America and Eli Lilly and Company have reported results of the pre-specified safety analysis from the INTREPID trial, a phase IV study designed to evaluate Livalo (pitavastatin) 4mg against pravastatin 40mg in HIV-infected patien… (Source: Drug Development Technology)
Source: Drug Development Technology - June 18, 2013 Category: Pharmaceuticals Source Type: news

Risk of Diabetes With Statins Risk of Diabetes With Statins
While one study is reassuring for older patients treated with statins, with researchers finding no evidence of an increased risk of diabetes in acute coronary syndrome patients, the other suggests that the more potent statins, such as rosuvastatin, atorvastatin, and simvastatin, do pose an increased risk compared with pravastatin. Heartwire (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 24, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Two studies address diabetes risks with statins—one good news, one so-so
While one study is reassuring for older patients treated with statins, with researchers finding no evidence of an increased risk of diabetes in acute coronary syndrome patients, the other suggests that the more potent statins, such as rosuvastatin, atorvastatin, and simvastatin, do pose an increased risk compared with pravastatin. (Source: theHeart.org)
Source: theHeart.org - May 23, 2013 Category: Cardiology Source Type: news

Horizon Scanning: Pitavastatin versus pravastatin for LDL cholesterol reduction in HIV infected adults with dyslipidaemia
Source: BioSpace Area: News According to a report in BioSpace, results of a comparative superiority study investigating pitavastatin 4mg versus pravastatin 40mg in adult HIV infected patients with dyslipidaemia met its primary endpoint, percent reduction in LDL cholesterol, and reported that, after 12 weeks of therapy, pitavastatin had a significantly greater decrease in LDL cholesterol compared with pravastatin (pitavastatin 31% vs. pravastatin 21% reduction, p
Source: NeLM - Cardiovascular Medicine - March 8, 2013 Category: Cardiology Source Type: news